Search NASA⌕ Search

SEARCH · Search NASA

Results for “RPC”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 127 records · Page 7

Distributed Training for High Resolution Images: A Domain and Spatial Decomposition Approach

In this work we developed two Pytorch libraries using the PyTorch RPC interface for distributed deep learning approaches on high resolution images. The spatial decomposition library allows for distributed training on very large images, which otherwise wouldn’t be possible on a single GPU. The domain parallelism library allows for distributed training across multiple domain unlabeled data, by leveraging the domain separation architecture. Both of those libraries where tested on the Summit supercomputer at Oak Ridge National Laboratory at a moderate scale.

Tsaris, Aristeidis (aris)↗

Electronically Conductive Vanadate Glasses for Resistive Plate Chamber Particle Detectors

Particle detectors are constantly being built and refitted with new technology to improve the spatial resolution, radiation hardness, and speed at which the detector can capture particle events. One of the most crucial components of a modern collider experiment is the hadron calorimeter. One of the proposed improvements on future hadron calorimeters is to utilize resistive plate chambers (RPCs). They provide the spatial and energy resolution as well as could provide speed and radiation hardness. RPCs depend on manufacturing electrically conductive glasses that are mechanically strong, durable, radiation resistant, and not ionically conductive. To achieve such requirements, vanadate glasses were developed as alternatives to current prototypes which use soda lime silicate glasses. The conductivity, oxidation states of vanadium, radiation hardness, as well as the prototype performance, were tested on vanadate glasses. The prototype tests show that using 0.40ZnO−0.40TeO 2 −0.20V 2 O 5 can improve the RPC detector rate up to 100 times.

Johnson, Nicole↗

Report of AAPM Therapy Physics Committee Task Group 74: In-air output ratio, S{sub c}, for megavoltage photon beams

The concept of in-air output ratio (S{sub c}) was introduced to characterize how the incident photon fluence per monitor unit (or unit time for a Co-60 unit) varies with collimator settings. However, there has been much confusion regarding the measurement technique to be used that has prevented the accurate and consistent determination of S{sub c}. The main thrust of the report is to devise a theoretical and measurement formalism that ensures interinstitutional consistency of S{sub c}. The in-air output ratio, S{sub c}, is defined as the ratio of primary collision water kerma in free-space, K{sub p}, per monitor unit between an arbitrary collimator setting and the reference collimator setting at the same location. Miniphantoms with sufficient lateral and longitudinal thicknesses to eliminate electron contamination and maintain transient electron equilibrium are recommended for the measurement of S{sub c}. The authors present a correction formalism to extrapolate the correct S{sub c} from the measured values using high-Z miniphantom. Miniphantoms made of high-Z material are used to measure S{sub c} for small fields (e.g., IMRT or stereotactic radiosurgery). This report presents a review of the components of S{sub c}, including headscatter, source-obscuring, and monitor-backscattering effects. A review of calculation methods (Monte Carlo and empirical) used to calculate S{sub c} for arbitrary shaped fields is presented. The authors discussed the use of S{sub c} in photon dose calculation algorithms, in particular, monitor unit calculation. Finally, a summary of S{sub c} data (from RPC and other institutions) is included for QA purposes.

61 RADIATION PROTECTION AND DOSIMETRY↗

Dose calculation for permanent prostate implants incorporating spatially anisotropic linearly time-resolving edema

Purpose: The objectives of this study were (i) to develop a dose calculation method for permanent prostate implants that incorporates a clinically motivated model for edema and (ii) to illustrate the use of the method by calculating the preimplant dosimetry error for a reference configuration of {sup 125}I, {sup 103}Pd, and {sup 137}Cs seeds subject to edema-induced motions corresponding to a variety of model parameters. Methods: A model for spatially anisotropic edema that resolves linearly with time was developed based on serial magnetic resonance imaging measurements made previously at our center to characterize the edema for a group of n=40 prostate implant patients [R. S. Sloboda et al., ''Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging,'' Brachytherapy 9, 354-361 (2010)]. Model parameters consisted of edema magnitude, {Delta}, and period, T. The TG-43 dose calculation formalism for a point source was extended to incorporate the edema model, thus enabling calculation via numerical integration of the cumulative dose around an individual seed in the presence of edema. Using an even power piecewise-continuous polynomial representation for the radial dose function, the cumulative dose was also expressed in closed analytical form. Application of the method was illustrated by calculating the preimplant dosimetry error, RE{sub preplan}, in a 5x5x5 cm{sup 3} volume for {sup 125}I (Oncura 6711), {sup 103}Pd (Theragenics 200), and {sup 131}Cs (IsoRay CS-1) seeds arranged in the Radiological Physics Center test case 2 configuration for a range of edema relative magnitudes ({Delta}=[0.1,0.2,0.4,0.6,1.0]) and periods (T=[28,56,84] d). Results were compared to preimplant dosimetry errors calculated using a variation of the isotropic edema model developed by Chen et al. [''Dosimetric effects of edema in permanent prostate seed implants: A rigorous solution,'' Int. J. Radiat. Oncol., Biol., Phys. 47, 1405-1419 (2000)]. Results: As expected, RE{sub preplan} for our edema model indicated underdosage in the calculation volume with a clear dependence on seed and calculation point positions, and increased with increasing values of {Delta} and T. Values of RE{sub preplan} were generally larger near the ends of the virtual prostate in the RPC phantom compared with more central locations. For edema characteristics similar to the population average values previously measured at our center, i.e., {Delta}=0.2 and T=28 d, mean values of RE{sub preplan} in an axial plane located 1.5 cm from the center of the seed distribution were 8.3% for {sup 131}Cs seeds, 7.5% for {sup 103}Pd seeds, and 2.2% for {sup 125}I seeds. Maximum values of RE{sub preplan} in the same plane were about 1.5 times greater. Note that detailed results strictly apply only for loose seed implants where the seeds are fixed in tissue and move in synchrony with that tissue. Conclusions: A dose calculation method for permanent prostate implants incorporating spatially anisotropic linearly time-resolving edema was developed for which cumulative dose can be written in closed form. The method yields values for RE{sub preplan} that differ from those for spatially isotropic edema. The method is suitable for calculating pre- and postimplant dosimetry correction factors for clinical seed configurations when edema characteristics can be measured or estimated.

60 APPLIED LIFE SCIENCES↗

Toward a better understanding of the gamma index: Investigation of parameters with a surface-based distance method

Purpose: The purpose of this work was to clarify the interactions between the parameters used in the {gamma} index with the surface-based distance method, which itself can be viewed as a generalized version of the {gamma} index. The examined parameters included the distance to agreement (DTA)/dose difference (DD) criteria, the percentage used as a passing criterion, and the passing percentage for given DTA/DD criteria. The specific aims of our work were (1) to understand the relationships between the parameters used in the {gamma} index, (2) to determine the detection limit, or the minimum detectable error, of the {gamma} index with a given set of parameters, and (3) to establish a procedure to determine parameters that are consistent with the capacity of an IMRT QA system. Methods: The surface-based distance technique with dose gradient factor was derived, and then the relationship between surface-based distance and {gamma} index was established. The dose gradient factor for plans and measurements of 10 IMRT patients, 10 spine stereotactic radiosurgery (SRS) patients, and 3 Radiological Physics Center (RPC) head and neck phantom were calculated and evaluated. The detection limits of the surface-based distance and {gamma} index methods were examined by introducing known shifts to the 10 IMRT plans. Results: The means of the dose gradient factors were 0.434 mm/% and 0.956 mm/% for the SRS and IMRT plans, respectively. Key quantities (including the mean and 90th and 99th percentiles of the distance distribution) of the surface-based distance distribution between two dose distributions were linearly proportional to the actual shifts. However, the passing percentage of the {gamma} index for a given set of DTA/DD criteria was not associated with the actual shift. For IMRT, using the standard quality assurance criteria of 3 mm/3% DTA/DD and a 90% passing rate, we found that the detection limit of the {gamma} index in terms of global shift was 4.07 mm/4.07 % without noise. Conclusions: Surface-based distance is a direct measure of the difference between two dose distributions and can be used to evaluate or determine parameters for use in calculating the {gamma} index. The dose gradient factor represents the weighting between spatial and dose shift and should be determined before DTA/DD criteria are set. The authors also present a procedure to determine {gamma} index parameters from measurements.

61 RADIATION PROTECTION AND DOSIMETRY↗

SU-E-P-03: Implementing a Low Dose Lung Screening CT Program Meeting Regulatory Requirements

Purpose: To provide information pertaining to IROC Houston QA Center's (RPC) credentialing process for institutions participating in NCI-sponsored clinical trials. Purpose: Provide guidance to the Radiology Departments with the intent of implementing a Low Dose CT Screening Program using different CT Scanners with multiple techniques within the framework of the required state regulations. Method: State Requirements for the purpose of implementing a Low Dose CT Lung Protocol required working with the Radiology and Pulmonary Department in setting up a Low Dose Screening Protocol designed to reduce the radiation burden to the patients enrolled. Radiation dose measurements (CTDIvol) for various CT manufacturers (Siemens16, Siemens 64, Philips 64, and Neusoft128) for three different weight based protocols. All scans were reviewed by the Radiologist. Prior to starting a low dose lung screening protocol, information had to be submitted to the state for approval. Performing a Healing Arts protocol requires extensive information. This not only includes name and address of the applicant but a detailed description of the disease, the x-ray examination and the population to be examined. The unit had to be tested by a qualified expert using the technique charts. The credentials of all the operators, the supervisors and the Radiologists had to be submitted to the state. Results: All the appropriate documentation was sent to the state for review. The measured results between the Low Dose Protocol versus the default Adult Chest Protocol showed that there was a dose reduction of 65% for small (100-150 lb.) patient, 75% for the Medium patient (151-250 lbs.), and a 55% reduction for the Large patient ( over 250 lbs.). Conclusion: Measured results indicated that the Low Dose Protocol indeed lowered the screening patient's radiation dose and the institution was able to submit the protocol to the State's regulators.

60 APPLIED LIFE SCIENCES↗

SU-E-T-87: Comparison Study of Dose Reconstruction From Cylindrical Diode Array Measurements, with TLD Measurements and Treatment Planning System Calculations in Anthropomorphic Head and Neck and Lung Phantoms

Purpose: To assess dose calculated by the 3DVH software (Sun Nuclear Systems, Melbourne, FL) against TLD measurements and treatment planning system calculations in anthropomorphic phantoms. Methods: The IROC Houston (RPC) head and neck (HN) and lung phantoms were scanned and plans were generated using Eclipse (Varian Medical Systems, Milpitas, CA) following IROC Houston procedures. For the H and N phantom, 6 MV VMAT and 9-field dynamic MLC (DMLC) plans were created. For the lung phantom 6 MV VMAT and 15 MV 9-field dynamic MLC (DMLC) plans were created. The plans were delivered to the phantoms and to an ArcCHECK (Sun Nuclear Systems, Melbourne, FL). The head and neck phantom contained 8 TLDs located at PTV1 (4), PTV2 (2), and OAR Cord (2). The lung phantom contained 4 TLDs, 2 in the PTV, 1 in the cord, and 1 in the heart. Daily outputs were recorded before each measurement for correction. 3DVH dose reconstruction software was used to project the calculated dose to patient anatomy. Results: For the HN phantom, the maximum difference between 3DVH and TLDs was -3.4% and between 3DVH and Eclipse was 1.2%. For the lung plan the maximum difference between 3DVH and TLDs was 4.3%, except for the spinal cord for which 3DVH overestimated the TLD dose by 12%. The maximum difference between 3DVH and Eclipse was 0.3%. 3DVH agreed well with Eclipse because the dose reconstruction algorithm uses the diode measurements to perturb the dose calculated by the treatment planning system; therefore, if there is a problem in the modeling or heterogeneity correction, it will be carried through to 3DVH. Conclusion: 3DVH agreed well with Eclipse and TLD measurements. Comparison of 3DVH with film measurements is ongoing. Work supported by PHS grant CA10953 and CA81647 (NCI, DHHS)

60 APPLIED LIFE SCIENCES↗

SU-E-T-167: Evaluation of Mobius Dose Calculation Engine Using Out of the Box Preconfigured Beam Data

Purpose: Determine the dose calculation accuracy of a preconfigured Mobius server for use in secondary checks of a treatment planning system. Methods: 10 plans were created for irradiation on two of the IROC (formerly RPC) accreditation phantoms: 4 for the head and neck phantom and 6 for the lung phantom. The plans each were created using one of four different photon energies (6FFF, 10 FFF, 6X, and 15X) and were varied in treatment type including VMAT, step and shoot IMRT, dynamic MLC IMRT (DMLC), and conformal RT (CRT). The TLDs in the phantoms were contoured, and each plan was sent for calculation to Mobius software (Mobius Medical Systems, Houston, TX) with a default configuration. Each plan was then irradiated on the planned phantom 3 times to create an average reading across 56 TLDs. These readings were then compared against the corresponding Mobius calculation at each TLD location. Results: The mean difference (MD) normalized to the plan prescription dose between each TLD and Mobius calculation for all measurements was 0.5 ± 3.3%, with a maximum difference of 8.4%. The MD was 0.6 ± 3.8%, − 2.0 ± 1.9%, 1.7 ± 3.7%, and 1.9 ± 1.2% across the 6FFF, 10FFF, 6X and 15X energies respectively. The MD was −1.2 ± 2.3% for lung plans and 1.8 ± 3.5% for head/neck plans. Across treatment types, the MD ranged from − 1.8 ± 1.7% for CRT to 4.3 ± 2.4 % for DMLC. Conclusion: Out of the box and preconfigured, Mobius provides accurate dose calculations with respect to beam energy, treatment type, and treatment site.

60 APPLIED LIFE SCIENCES↗

SU-E-T-509: Validation of the Use of OSLD for Carbon Beam Remote Dosimetry

Purpose: To describe the commissioning of Aluminum Oxide Optically Stimulated Luminescent Dosimeters (OSLD) for the use in Carbon beam remote dosimetry for centers participating in NCI-funded cooperative group clinical trials. Methods: As Carbon therapy centers express interest in participating in cooperative group clinical trials, the Imaging and Radiation Oncology Core Group (IROC) Houston QA Center (formerly RPC) is developing a way to remotely monitor the machine output of these Carbon facilities. OSLD have been commissioned for photon, electron and proton dosimetry, so an experiment was designed to commission the same dosimeters for Carbon. OSLD were irradiated in a Carbon therapy beam produced by the Siemens synchrotron at the Heidelberg Ion Therapy facility in Heidelberg, Germany. The OSLD were placed in acrylic phantoms, imaged with a CT scanner, and plans were developed using the Siemens treatment planning system. The OSLD were irradiated in uniform fields with maximum energies of 216, 301, and 402 MeV and at dose levels of 50, 100, 200 and 300 cGy. Results: The response of the OSLD in the Carbon beam, as compared to the Cobalt-60 reference condition, required an energy correction of 1.85 to account for the particle correction. OSLD dose calculations typically have a linearity correction to account for the change in response relative to the change in dose delivered. However, the response of the OSLD in the Carbon beam was found to be independent of the dose level; thus the linearity correction is 1.00. Conclusion: IROC Houston has commissioned OSLD for the use of remote output checks for Carbon therapy facilities to help ensure consistency across clinical trial participants. Work supported by grant CA10953 (NCI, DHHS)

07 ISOTOPE AND RADIATION SOURCES↗

SU-E-T-535: Preliminary 2D and 3D Gamma Calculation Comparison Using PRESAGE

Purpose: To compare gamma calculations from 2D and 3D dosimetry measurements for phantom quality assurance. Methods: An IROC Houston (RPC) head and neck phantom was irradiated with a 9 beam IMRT plan using two inserts: a TLD and film insert and a PRESAGE insert. Both inserts were irradiated 3 times. The film and PRESAGE doses were scaled to the TLD dose and 2D gamma calculations were made in the axial and sagittal planes bisecting the primary target. 3D gamma measurements were taken within the PRESAGE dosimeter volume. Gamma constraints of 3%/3mm distance to agreement (DTA), 5%/3mm DTA and 7%/4mm DTA were used in the study. The 3 irradiations for each insert were averaged together for comparison. Results: Film measurements for the 2D gamma showed 85% pixels passing at 3%/3mm in both planes. The 5%/3 mm constraint had 93% and 90% passing in the two planes. The 7%/4mm restraint resulted in 99% passing in both planes. The PRESAGE 2D gamma passed 66% and 61% of pixels in the both planes at 3%/3mm. At 5%/3mm 86% and 82% passed. For 7%/4mm, 94% of pixels passed in both planes. The 3D gamma resulted in a pass rate of 90% at 3%/3mm, 95% at 5%/3mm, and 99% at 7%/4mm. Conclusion: 2D gamma pass rates using film showed a higher pass rate than PRESAGE using the same criteria in the same planes. This may be due to poor 3D registration with the treatment plan compared to the 2D film registration system. The 3D gamma results had a higher pass rate (> 90% pass rate) possibly because it sampled many more pixels in noncritical volumes thus diluting the percent of pixels passing. 3D restraints should be more restrictive to be comparable to 2D results. Funding from NIH grant 5R01CA100835.

60 APPLIED LIFE SCIENCES↗

SU-E-T-543: Is It Feasible to Tighten the Criteria for IROC's Anthropomorphic Phantoms?

Purpose: To analyze results of IROC Houston QA center's (RPC) H and N and prostate IMRT phantoms to determine the effect that tightening criteria would have on the phantom pass rate. Methods: IROC Houston's anthropomorphic H and N and prostate phantoms are used to credential institution's to participate in NCI clinical trials that allow the use of IMRT. The phantoms are shipped to institutions where they are filled with water and undergo imaging, treatment planning, and irradiation as a patient would. Each phantom houses targets and organs at risk. They also hold film and TLD. Dosimeter results are compared to the institution's treatment plan using the criteria of 7% for PTV TLD doses and ≥85% pixels must pass 7%/4 mm global gamma analyses. Pass rates for the H and N and prostate phantoms were recalculated using the following tighter criteria options: 1) 5% TLD and 85% pixels 7%/4 gamma2) 5% TLD and 90% pixels 7%/4 gamma3) 5% TLD and 85% pixels 5%/4 gammaGamma analysis was repeated for the 30 most recent irradiations of each phantom to estimate results for criteria 3. Results: Pass rates using current criteria for the H and N and prostate phantoms are 84% and 85% respectively. Pass rates since gamma criteria were introduced in 2012 are 90% and 87%. Criteria 1 applied to all irradiations drops pass rates to 78% and 82%. Applying it to only irradiations with gamma results give 77% and 84%. Applying criteria 2 to only phantoms with gamma results drops pass rates to 80% and 74% and they fall to 83% and 67% respectively using criteria 3. Conclusion: Applying tighter criteria to phantom results has potential to increase quality in clinical trials. The results of the 30 most recent irradiations indicate that there may be room to tighten H and N phantom criteria in the future. Work supported by PHS grant CA10953 and CA081647 (NCI, DHHS)

60 APPLIED LIFE SCIENCES↗

SU-E-CAMPUS-T-03: Development and Implementation of An Anthropomorphic Pediatric Spine Phantom for the Assessment of Craniospinal Irradiation Procedures in Proton Therapy

Purpose: To design an anthropomorphic pediatric spine phantom for use in the evaluation of proton therapy facilities for clinical trial participation by the Imaging and Radiation Oncology Core (IROC) Houston QA Center (formerly RPC). Methods: This phantom was designed to perform an end-to-end audit of the proton spine treatment process, including simulation, dose calculation by the treatment planning system (TPS), and proton treatment delivery. The design incorporated materials simulating the thoracic spinal column of a pediatric patient, along with two thermoluminescent dosimeter (TLD)-100 capsules and radiochromic film embedded in the phantom for dose evaluation. Fourteen potential materials were tested to determine relative proton stopping power (RSP) and Hounsfield unit (HU) values. Each material was CT scanned at 120kVp, and the RSP was obtained from depth ionization scans using the Zebra multilayer ion chamber (MLIC) at two energies: 160 MeV and 250 MeV. To determine tissue equivalency, the measured RSP for each material was compared to the RSP calculated by the Eclipse TPS for a given HU. Results: The materials selected as bone, tissue, and cartilage substitutes were Techron HPV Bearing Grade (Boedeker Plastics, Inc.), solid water, and blue water, respectively. The RSP values did not differ by more than 1.8% between the two energies. The measured RSP for each selected material agreed with the RSP calculated by the Eclipse TPS within 1.2%. Conclusion: An anthropomorphic pediatric proton spine phantom was designed to evaluate proton therapy delivery. The inclusion of multiple tissue substitutes increases heterogeneity and the level of difficulty for institutions to successfully treat the phantom. The following attributes will be evaluated: absolute dose agreement, distal range, field width, junction match and right/left dose profile alignment. The phantom will be tested at several institutions using a 5% dose agreement criterion, and a 5%/3mm gamma analysis criterion for the film planes. Work supported by grants CA10953, CA059267, and CA81647 (NCI, DHHS)

07 ISOTOPE AND RADIATION SOURCES↗

SU-F-BRE-06: Evaluation of Patient CT Dose Reconstruction From 3D Diode Array Measurements Using Anthropomorphic Phantoms

Purpose: To compare 3D reconstructed dose of IMRT plans from 3D diode array measurements with measurements in anthropomorphic phantoms. Methods: Six IMRT plans were created for the IROC Houston (RPC) head and neck (H and N) and lung phantoms following IROC Houston planning protocols. The plans included flattened and unflattened beam energies ranging from 6 MV to 15 MV and both static and dynamic MLC tecH and Niques. Each plan was delivered three times to the respective anthropomorphic phantom, each of which contained thermoluminescent dosimeters (TLDs) and radiochromic films (RCFs). The plans were also delivered to a Delta4 diode array (Scandidos, Uppsala, Sweden). Irradiations were done using a TrueBeam STx (Varian Medical Systems, Palo Alto, CA). The dose in the patient was calculated by the Delta4 software, which used the diode measurements to estimate incident energy fluence and a kernel-based pencil beam algorithm to calculate dose. The 3D dose results were compared with the TLD and RCF measurements. Results: In the lung, the average difference between TLDs and Delta4 calculations was 5% (range 2%–7%). For the H and N, the average differences were 2.4% (range 0%–4.5%) and 1.1% (range 0%–2%) for the high- and low-dose targets, respectively, and 12% (range 10%-13%) for the organ-at-risk simulating the spinal cord. For the RCF and criteria of 7%/4mm, 5%/3mm, and 3%/3mm, the average gamma-index pass rates were 95.4%, 85.7%, and 76.1%, respectively for the H and N and 76.2%, 57.8%, and 49.5% for the lung. The pass-rate in the lung decreased with increasing beam energy, as expected for a pencil beam algorithm. Conclusion: The H and N phantom dose reconstruction met the IROC Houston acceptance criteria for clinical trials; however, the lung phantom dose did not, most likely due to the inaccuracy of the pencil beam algorithm in the presence of low-density inhomogeneities. Work supported by PHS grant CA10953 and CA81647 (NCI, DHHS)

60 APPLIED LIFE SCIENCES↗

MO-E-18C-01: Open Access Web-Based Peer-To-Peer Training and Education in Radiotherapy

Purpose: Current training and education delivery models have limitations which result in gaps in clinical proficiency with equipment, procedures, and techniques. Educational and training opportunities offered by vendors and professional societies are by their nature not available at point of need or for the life of clinical systems. The objective of this work is to leverage modern communications technology to provide peer-to-peer training and education for radiotherapy professionals, in the clinic and on demand, as they undertake their clinical duties. Methods: We have developed a free of charge web site ( https://i.treatsafely.org ) using the Google App Engine and datastore (NDB, GQL), Python with AJAX-RPC, and Javascript. The site is a radiotherapy-specific hosting service to which user-created videos illustrating clinical or physics processes and other relevant educational material can be uploaded. Efficient navigation to the material of interest is provided through several RT specific search tools and videos can be scored by users, thus providing comprehensive peer review of the site content. The site also supports multilingual narration\translation of videos, a quiz function for competence assessment and a library function allowing groups or institutions to define their standard operating procedures based on the video content. Results: The website went live in August 2013 and currently has over 680 registered users from 55 countries; 27.2% from the United States, 9.8% from India, 8.3% from the United Kingdom, 7.3% from Brazil, and 47.5% from other countries. The users include physicists (57.4%), Oncologists (12.5%), therapists (8.2%) and dosimetrists (4.8%). There are 75 videos to date including English, Portuguese, Mandarin, and Thai. Conclusion: Based on the initial acceptance of the site, we conclude that this open access web-based peer-to-peer tool is fulfilling an important need in radiotherapy training and education. Site functionality should expand in the future to include document sharing and continuing education credits.

61 RADIATION PROTECTION AND DOSIMETRY↗

MO-G-BRE-02: A Survey of IMRT QA Practices for More Than 800 Institutions

Purpose: A wide range of techniques and measurement devices are employed for IMRT QA, causing a large variation of accepted action limits and potential follow up for failing plans. Such procedures are not well established or accepted in the medical physics community. To achieve the goal of proving insight into current IMRT QA practices, we created an electronic IMRT QA survey. The survey was open to a variety of the most common QA devices and assessed the type of comparison to measurement, action limits, delivery methods, and clinical action for failing QA plans. Methods: We conducted an online survey through the Radiological Physics Center's (RPC) annual survey with the goal of ascertaining elements of routine patient-specific IMRT QA. A total of 874 institutions responded to the survey. The questions ranged from asking for action limits, dosimeter type(s) used, delivery techniques, and actions taken when a plan fails IMRT QA. Results: The most common (52%) planar gamma criteria was 3%/3 mm with a 95% of pixels passing criteria. The most common QA device were diode arrays (48%). The most common first response to a plan failing QA was to re-measure at the same point the point dose (89%), second was to re-measure at a new point (13%), and third was to analyze the plan in relative instead of absolute mode (10%) (Does not add to 100% as not all institutions placed a response for each QA follow-up option). Some institutions, however, claimed that they had never observed a plan failure. Conclusion: The survey provided insights into the way the community currently performs IMRT QA. This information will help in the push to standardize action limits among dosimeters.

60 APPLIED LIFE SCIENCES↗

TU-C-9A-01: IROC Organization and Clinical Trial Credentialing

As a response to recommendations from a report from the Institute of Medicine, NCI is reorganizing it clinical trial groups into a National Clinical Trial Network (NCTN) that consists of four adult groups (Alliance, ECOGACRIN, NRG, and SWOG) and one children’s group (COG). NRG will house CIRO, a center to promote innovative radiation therapy research and intergroup collaboration in radiation. The quality assurance groups that support clinical trials have also been restructured. ITC, OSU Imaging corelab, Philadelphia Imaging core-lab, QARC, RPC, and RTOGQA have joined together to create the Imaging and Radiation Oncology Core (IROC) Group. IROC’s mission is to provide integrated radiation oncology and diagnostic imaging quality control programs in support of the NCI’s NCTN thereby assuring high quality data for clinical trials designed to improve the clinical outcomes for cancer patients worldwide. This will be accomplished through five core services: site qualification, trial design support, credentialing, data management, case review.These changes are important for physicist participating in NCI clinical trials to understand. We will describe in detail the IROC’s activities and five core services so that as a user, the medical physicist can learn how to efficiently utilize this group. We will describe common pitfalls encountered in credentialing for current protocols and present methods to avoid them. These may include the which benchmarks are required for NSABP B-51/RTOG 1304 and how to plan them as well as tips for phantom planning. We will explain how to submit patient and phantom cases in the TRIAD system used by IROC. Learning Objectives: To understand the basic organization of IROC, its mission and five core services To learn how to use TRIAD for patient and phantom data submission To learn how to avoid common pitfalls in credentialing for current trials.

60 APPLIED LIFE SCIENCES↗

SU-E-J-208: Feasibility Study On Using Small Plastic Phantoms for Auditing Radiation Output of MR-Linac Systems

Purpose: To study feasibility of using small plastic phantoms designed for conventional linac output auditing to measure the output of MR-Linac systems. Methods: For simulations, the CT scan of an IROC(formerly RPC) acrylic block phantom designed for 8 MV beams was imported in a research version of the treatment planning system (Monaco). Dose delivered to three TLDs in the block was calculated with a Monte Carlo algorithm and a beam model based on an MR-linac prototype with and without a magnetic field (B=1.5T). In a large mathematical water phantom, the same beam was used to calculate dose in full scatter conditions. The block factor (F) was calculated as the ratio of the average dose to the block TLDs to the dose at the reference point in the mathematical phantom. For experimental measurement, four IROC blocks were irradiated with the MR-linac prototype, and data were analyzed by IROC. Results: The F factor without a B field was 1.053. When a B field was applied, it changed the dose distribution in the block, especially on the edges. With a B field parallel to the long axes of the TLD, F was 1.038. However, with a perpendicular B field, F factor increased slightly to 1.075. In the IROC report, the output determined with two blocks parallel to the B field was 2.3% higher than the output by the two blocks perpendicular to the B field. The average of all four blocks was within 2% of machine output measured with an ion chamber. Conclusion: It may be feasible to expand the utility of the acrylic block phantoms for radiation output auditing from conventional linacs to MR-linacs. However, the scatter correction factor can change due to the B field and its orientation to the block. More symmetric phantom designs may be less prone to mistakes. We acknowledge research support from Elekta.

60 APPLIED LIFE SCIENCES↗

TU-G-BRD-06: The Imaging and Radiation Oncology Core Houston (IROC Houston) QA Center International Activities Outside North America

Purpose: To describe the extent of IROC Houston’s (formerly the RPC) QA activities and audit results for radiotherapy institutions outside of North America (NA). Methods: The IROC Houston’s QA program components were designed to audit the radiation dose calculation chain from the NIST traceable reference beam calibration, to inclusion of dosimetry parameters used to calculate tumor doses, to the delivery of the radiation dose. The QA program provided to international institutions includes: 1) remote TLD/OSLD audit of machine output, 2) credentialing for advanced technologies, and 3) review of patient treatment records. IROC Houston uses the same standards and acceptance criteria for all of its audits whether for North American or international sites. Results: IROC Houston’s QA program has reached out to radiotherapy sites in 43 different countries since 2013 through their participation in clinical trials. In the past two years, 2,778 international megavoltage beam outputs were audited with OSLD/TLD. While the average IROC/Inst ratio is near unity for all sites monitored, there are international regions whose results are significantly different from the NA region. In the past 2 years, 477 and 87 IMRT H&N phantoms were irradiated at NA and international sites, respectively. Regardless of the OSLD beam audit results, the overall pass rate (87 percent) for all international sites (no region separation) is equal to the NA sites. Of the 182 international patient charts reviewed, 10.7 percent of the dose calculation points did not meet our acceptance criterion as compared to 13.6 percent for NA sites. The lower pass rate for NA sites results from a much larger brachytherapy component which has been shown to be more error prone. Conclusion: IROC Houston has expanded its QA services worldwide and continues a long history of improving radiotherapy dose delivery in many countries. Funding received for QA audit services from the Korean GOG, DAHANCA, EORTC, ICON and CMIC Group.

60 APPLIED LIFE SCIENCES↗